ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma

ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma

[at noodls] – Restructuring to Place Exclusive Strategic Focus on Synthetic Biology Programs Company to Host Conference Call Today, March 26, 2013 at 8:30 AM ET NEW YORK, March 26, 2013 (GLOBE NEWSWIRE) — ZIOPHARM … more

View todays social media effects on ZIOP

View the latest stocks trending across Twitter. Click to view dashboard

See who ZIOPHARM is hiring next, click here to view

Share this post